ѻý

HeartMate 3 Safety Concerns; First Cath Lab Standards for Kids; Single-Shot PFA

<ѻý class="mpt-content-deck">— Recent developments of interest in cardiovascular medicine
MedpageToday
Cardio Break over a computer rendering of a heart.

Thoratec refuted most of the 4,500-plus reports that its may have caused or contributed to a patient's death. (CBS News)

Cardiovascular societies have finally released pediatric cardiac catheterization standards in an updated expert consensus statement on . (JSCAI)

Researchers linked reduced to both genetic predisposition and exercise training. (Circulation)

Gripped by the opioid crisis, bucked favorable national trends in mortality due to infective endocarditis. (Journal of the American Heart Association)

In the Evolut trial, low-risk patients undergoing transcatheter or surgical aortic valve replacement wound up spending . (Circulation: Cardiovascular Quality and Outcomes)

Although underpowered, the randomized RAPID NSTEMI trial failed to find a clinical benefit to for higher-risk patients with non-ST-elevation acute coronary syndrome. (Heart)

Esperion announced that the FDA approved primary hyperlipidemia as part of the indication for and had some qualifiers on the label removed.

Government emails reveal pressures to in the U.K. (Pharmaceutical Journal)

Perimenopausal women taking hormone therapy showed a decreased risk of venous thromboembolism . (JAMA Network Open)

A call to action urges the creation of a , an early bundle of care for patients with intracerebral hemorrhage akin to current strategies used for acute ischemic stroke. (Stroke)

The prognostic significance of depends on whether they are detected by transesophageal echocardiography or CT, according to a meta-analysis. (European Heart Journal)

The mineralocorticoid receptor antagonist reduced arterial inflammation in HIV-positive patients without known cardiovascular disease. (JAMA Cardiology)

A did not affect left atrial substrate measurements in overweight or obese people with metabolic syndrome. (European Journal of Preventive Cardiology)

A preclinical study opened the door for single-shot circumferential pulmonary vein isolation using a . (EP Europace)

, a type of stem cell therapy, showed promise in a phase Ia/b study in pulmonary arterial hypertension. (eBioMedicine)

A was found to correlate with cardiovascular events and all-cause mortality. (The Lancet Regional Health-Europe)

A Brooklyn cardiologist was related to his alleged scheme of subjecting patients to unnecessary peripheral vascular interventional procedures and paying other physicians for patient referrals, the U.S. Attorney's Office announced.

  • author['full_name']

    Nicole Lou is a reporter for ѻý, where she covers cardiology news and other developments in medicine.